← Evidence map

ArticleTherapeutic advances in drug safety2019

Risk of bronchospasm and coronary arteriospasm with sugammadex use: a post marketing analysis.

Pushkar AggarwalPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2019
2020
2021
2022
2023
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 31452867